Levels of soluble cell adhesion molecules in patients with dyslipidemia
about
Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trialQuantitative trait locus analysis of circulating adhesion molecules in hyperlipidemic apolipoprotein E-deficient mice.Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study.The associations between serum leptin, adiponectin and intercellular adhesion molecule-1 in hypercholesterolemic patients.Testing for endothelial dysfunction.Effects of diet and of dietary components on endothelial leukocyte adhesion molecules.Pleiotropic effects of statins.Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis.Endothelial dysfunction in the pathogenesis of atherosclerosis.Statins and inflammatory markers.Changes in the vascular cell adhesion molecule-1, intercellular adhesion molecule-1 and c-reactive protein following administration of aqueous extract of piper sarmentosum on experimental rabbits fed with cholesterol diet.The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases.Lack of therapeutic interchangeability of HMG-CoA reductase inhibitors.Association of biomarkers of inflammation with dyslipidemia and its components among Mongolians in China.High glucose-treated macrophages augment E-selectin expression in endothelial cells.Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction.Elevated circulating vascular cell Adhesion Molecule-1 (sVCAM-1) is associated with concurrent depressive symptoms and cerebral white matter Hyperintensities in older adults.Expression of vascular cell adhesion molecule-1 in the aortic tissues of atherosclerotic patients and the associated clinical implications.The relationship between the serum intercellular adhesion molecule-1 level and the prognosis of the disease in lung cancerExamining Endothelial Function and Platelet Reactivity in Patients with Depression before and after SSRI TherapyCirculating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.Relation Between Circulating Inflammatory Chemokines and Vascular Characteristics in Healthy, Young Children.Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB.Effects of angiotensin II-receptor blockers on soluble cell adhesion molecule levels in uncomplicated systemic hypertension: An observational, controlled pilot study in Taiwanese adults.Problems and promise of immunological factors as biomarkers for schizophrenia.Influence of periodontal intervention therapy on risk of cardiovascular disease.Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells.Normal and pathologic concentrations of uremic toxins.Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells.Poloxamer 407 increases soluble adhesion molecules, ICAM-1, VCAM-1 and E-selectin, in C57BL/6 mice.Atorvastatin: beyond lipid-lowering effects in the diabetic population.s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal.Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitis.The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha.Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.Intercellular adhesion molecule-1 expression in the hippocampal CA1 region of hyperlipidemic rats with chronic cerebral ischemia.Pleiotropic effects of atorvastatin on monocytes in atherosclerotic patients.Extent of coronary atherosclerosis and homocysteine affect endothelial markers.Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women.
P2860
Q24806105-4D7E26DF-4FE8-4712-AEAC-673E499E1921Q30440350-E85245E3-7C39-4453-9941-B03B504D24BBQ33571435-7267644C-B39D-452A-ABB6-B490D8F2C922Q33901314-FE73D5AA-33EC-47BA-BC63-B3A849B3A71CQ34008359-01E89B7B-0C76-4EED-A72B-0AF58B2FAA05Q34107251-0507E5E3-F2E6-4E72-9FDC-074CC48D9823Q34107414-BA4B875B-57C3-42FA-A760-9A9A653AA96CQ34107489-BCE67214-D3A1-46C5-AE19-EA01CB39344CQ34430443-357D9ED1-1A0F-4559-82C9-F657E8D4CB12Q34482145-41FE9FF2-3971-4D95-B7BB-F218FC9A8A7AQ34506527-ED5EA908-D85A-4FBA-94FF-91FA3AD7E73AQ34552443-44E6DDDD-4404-45F2-AA20-515BD9E0913EQ35009456-2AE3FDB8-7AA4-42FC-BD3C-FAD9FF3363ECQ35099775-D8A251F4-AA8A-4ABB-903A-A1957A45E86FQ35111015-C92BCE65-97CD-4BE3-B2F3-057155C07080Q35544330-18D3782E-8307-492D-8685-D1C2F32319B9Q35651808-1F786DC1-C715-45B7-8BA3-8E8D28A26651Q35870501-0460A290-149F-48B0-87E3-043F2720EBD4Q35936789-02E17136-D30B-46F7-A678-B5A37819C13DQ35939221-639A7D98-B441-4023-A34E-A3307BC3CE0AQ35950454-1DF3D38E-F940-4F31-A65F-CBD756F4FC9AQ36836407-ED81A39E-00F1-445A-AA86-C48134EDE7C7Q37575951-79BAAD11-28E6-4742-87CC-4DCF773F9FC9Q37661006-6D82AC09-3959-4DC9-B1A0-E77B56EAFA84Q37755088-62AA4BA7-AD55-4055-BAE1-52B62309CC3BQ37866360-10BDDC75-EC2A-4416-9075-AE37FB19B9BAQ37867718-8CD18219-7EB1-4906-A77A-0E35239C8F06Q38012908-1E0B02B2-E822-47E1-8A8A-205D5E9EBD7FQ39799854-3608DB0A-6688-4404-9DF3-AB866D2338BBQ39923102-CE75404F-A513-4360-9E0E-D3656142B6AAQ40292972-11FD9547-0980-4EC0-A563-5BE20D9C01D5Q42703085-AC0F3598-39F2-48C6-A858-D0F54B5BB727Q42770007-FD609EA4-7101-4B97-B521-AA31ED3AD378Q42809919-26B1BF2C-100E-4FCA-891B-D298FD30F101Q42831410-716E51F6-02A9-439A-8162-863F56011416Q43121577-DC88E67F-B790-4D7F-A5AF-DCAD74AC56EDQ43266162-7EFE5211-35EB-4643-B29A-71AB3786E518Q43746630-1831B52B-2E28-4A2C-BCC0-3C1884447CDEQ43837381-B927BB02-86CB-45AD-A9A6-F05549C5770FQ43922726-8EB0B8D3-5DF0-4100-B697-AA07A628BD41
P2860
Levels of soluble cell adhesion molecules in patients with dyslipidemia
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@ast
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@en
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@nl
type
label
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@ast
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@en
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@nl
prefLabel
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@ast
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@en
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@nl
P2093
P356
P1433
P1476
Levels of soluble cell adhesion molecules in patients with dyslipidemia
@en
P2093
C M Ballantyne
P304
P356
10.1161/01.CIR.93.7.1334
P407
P577
1996-04-01T00:00:00Z